When to place permanent dialysis access in Chronic Kidney Disease (CKD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Permanent dialysis access should be placed when a patient with chronic kidney disease (CKD) has an estimated glomerular filtration rate (eGFR) of less than 20-25 mL/min/1.73m² and is expected to require dialysis within the next 6-12 months, as recommended by the most recent guidelines 1.

Key Considerations

  • The timing of access placement should be individualized based on the rate of kidney function decline, with patients experiencing rapid progression (>5 mL/min/year decrease in eGFR) requiring earlier access planning 1.
  • Clinical indicators that suggest the need for access placement include worsening uremic symptoms, difficult-to-control hypertension, volume overload resistant to diuretics, and persistent electrolyte abnormalities 1.
  • Nephrologists typically monitor these parameters along with laboratory values like creatinine, BUN, potassium, and bicarbonate levels to determine optimal timing 1.
  • Early access planning is crucial because it reduces the need for temporary catheters, which carry higher infection risks and mortality rates 1.

Access Type and Timing

  • Arteriovenous fistulas (AVFs) should be created at least 3-6 months before anticipated dialysis initiation to allow adequate maturation time 1.
  • Arteriovenous grafts (AVGs) need about 2-3 weeks to heal before use 1.
  • Peritoneal dialysis catheters should be placed 2-4 weeks before anticipated use to allow for healing of the exit site 1.

Benefits of Early Access Planning

  • Reduces the need for temporary catheters and associated complications 1.
  • Allows for timely creation and maturation of permanent access, reducing the risk of access-related morbidity and mortality 1.
  • Improves patient outcomes and quality of life by enabling timely initiation of dialysis therapy 1.

From the Research

Timing of Permanent Dialysis Access Placement

  • Permanent dialysis access should be placed when the patient's estimated glomerular filtration rate (GFR) is less than 20 ml/min 2
  • The access should be placed at least 6 months before the start of hemodialysis (HD) in the case of native arteriovenous (AV) fistulae and 3-6 weeks before in the case of synthetic AV grafts 2
  • Patients with chronic kidney disease (CKD) should be referred for hemodialysis access when their estimated GFR progressively decreases to 15 to 20 mL/min, or when their peritoneal dialysis, kidney transplant, or current vascular access is failing 3

Patient Evaluation and Preparation

  • Early referral of patients with advanced CKD (GFR <or= 30 ml/min: CKD stage 4) is necessary for education about different modalities of kidney replacement therapy and to allow sufficient time for permanent functioning vascular access placement before HD initiation 2
  • Patients should limit or avoid vascular procedures that may complicate future arteriovenous access, such as antecubital venipuncture or peripheral insertion of central catheters 3

Type and Location of Permanent Vascular Access

  • A native AV fistula is the preferred type of vascular access, with a wrist (radial-cephalic) primary AV fistula being the first choice 2
  • The location of the vascular access should be chosen based on patient anatomy and preferences, with the goal of preserving vein integrity for future access sites 4

Maturation and Care of Vascular Access

  • A native AV fistula should not be used for at least 6-8 weeks after placement to allow for maturation 2
  • Patients should be educated on the importance of protecting their vascular access and recognizing signs of complications, such as infection or thrombosis 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2008

Research

Strategies for Hemodialysis Access: A Vascular Surgeon's Perspective.

Techniques in vascular and interventional radiology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.